Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-19-001276
Filing Date
2019-02-13
Accepted
2019-02-13 12:02:42
Documents
1
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155007734689503.html 3  
1 FORM 3 wf-form3_155007734689503.xml 3 28931
  Complete submission text file 0001628280-19-001276.txt   30437
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Issuer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals

Mailing Address C/O KERYX BIOPHARMACEUTICALS 750 LEXINGTON AVENUE NEW YORK X1 10022
Business Address
Kaye Jack (Reporting) CIK: 0001376099 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55264 | Film No.: 19595105